Free Trial

SenesTech Q2 2023 Earnings Report

SenesTech logo
$3.13 +0.33 (+11.79%)
As of 03:59 PM Eastern

SenesTech EPS Results

Actual EPS
-$84.00
Consensus EPS
-$93.60
Beat/Miss
Beat by +$9.60
One Year Ago EPS
N/A

SenesTech Revenue Results

Actual Revenue
$0.31 million
Expected Revenue
$0.36 million
Beat/Miss
Missed by -$50.00 thousand
YoY Revenue Growth
N/A

SenesTech Announcement Details

Quarter
Q2 2023
Time
N/A

Conference Call Resources

SenesTech Earnings Headlines

StockNews.com Begins Coverage on SenesTech (NASDAQ:SNES)
I was wrong. Dead wrong.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
SenesTech (NASDAQ:SNES) Coverage Initiated at StockNews.com
See More SenesTech Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like SenesTech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on SenesTech and other key companies, straight to your email.

About SenesTech

SenesTech (NASDAQ:SNES) develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

View SenesTech Profile

More Earnings Resources from MarketBeat